If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Marketing Management » Marketing Strategy
Download FREE Excerpt
15 Info Graphics
4 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Disease state awareness campaigns have long been used by the pharmaceutical industry to disseminate unbranded information to key external stakeholders, such as physicians and patients. These programs also set the table for future marketing efforts at product launch and post-launch. Today, more than ever, understanding how to utilize these programs is critical.
Best Practices, LLC conducted a primary research study that looked at issues such as when are companies first using disease awareness programs and when should you invest the most resources in disease awareness campaigns?
The study provides highlights from interviews, spotlighting effective practices and challenges participants have faced regarding disease awareness programs. In addition, this document presents best practices and pitfalls that participants have learned from past disease awareness campaigns.
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Public Relations; Health Care; Biopharmaceutical
Bayer; Abbvie; Genzyme; Adamas Pharmaceuticals; AstraZeneca; Biogen; Novartis; Eli Lilly; FleishmanHillard; Fresenius Medical Care AG & Co. KGaA; ZS Pharma; Indivior; Merck; Catalyst Pharmaceuticals; Prometheus Therapeutics & Diagnostics; Tokai Pharmaceuticals; Vertex Pharmaceuticals